Hetero's biologics arm, Hetero Biopharma will manufacture the drug at its dedicated biologics facility, based at Jadcherla in Hyderabad.
This is the world's first DNA-based vaccine against the coronavirus, and this three-dose vaccine when injected produces the spike protein of the SARS-CoV-2 virus and elicits an immune response.
Another giant pharma company Moderna is supposed to donate seven million doses to India from the United States under Covax is still pending.
'India to make 850 millon Sputnik doses annually': Vaccine makers lay out production plans after getting DGCI approval
The Drug Controller General of India (DCGI) has registered the vaccine under the emergency use authorisation procedure.
Sources said that with government's action against the China firms, India may witness a shortage of medicines, including for vital diseases such as cancer, for a couple of months.